Adaptimmune Therapeutics plc
- Targets
- 1
- Filings
- 1
- Median premium
- 51%
- First filing
- Apr 20, 2023
- Latest filing
- Apr 20, 2023
Targets
| Company | Score before deal | Score now | Filings | Latest |
|---|---|---|---|---|
| TCR2 THERAPEUTICS INC. | — | — | 1 | Apr 20, 2023 |
Deal filings
| Filed | Company | Form | Price | Premium |
|---|---|---|---|---|
| Apr 20, 2023 | TCR2 THERAPEUTICS INC. | DEFM14A | $1.51 | 51.17% |